Our findings indicate that miR-200a mitigates fibrosis by downregulating MMPs and PAI-1 while upregulating uPA and uPAR, suggesting a protective role of miR-200a and its potential as a therapeutic target for pulmonary fibrosis. This evidence concerns the gene PLAUR and pulmonary fibrosis.